One of the possible reasons for this is that metformin inhibits sodium-glucose cotransporter1 (SGLT1) on small intestinal epithelial cells, decreasing the intra- and extracellular Na + concentration gradient, thereby inhibiting intestinal glucose absorption and increasing glucose utilization (Lenzen et al., 1996
As in the pathophysiology of DR, RGCs are particularly vulnerable to oxidative stressors in glaucoma
Persona Sections For New Researchers / Beginners What a COA is, how to interpret it Guidelines for selecting reagent grade vs research grade Safety disclaimers and laboratory best practices For Intermediate Users Comparing nootropics vs peptides vs SARMs How to stack nootropics, solvent compatibility, storage Basic stability and solubility notes For Advanced / Institutional Labs Bulk ordering, traceability, method transfer Analytical contracts, custom testing, GMP bridging Cross-lab reproducibility protocols Authoritative & External References GoodRx: What Are SARMs
Well firstly, Im using an oral formulation of the molecule rather than an injectable one
Most recently, over the past 2 years, Ive been taking a GLP-1 medication (Mounjaro, now Zepbound) which has been life changing